Providence Therapeutics’ mRNA rabies vaccine hits milestone
Providence Therapeutics Holdings Inc. says its new mRNA vaccine program for rabies post-exposure prophylaxis has…
December 16, 2022 - 2 minutes
Providence Therapeutics Holdings Inc. says its new mRNA vaccine program for rabies post-exposure prophylaxis has…